Northern Trust
BIAF icon

Northern Trust’s bioAffinity Technologies BIAF Stock Holding History

Northern Trust’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
1,117
+269
+32% +$8.24K ﹤0.01% 4397
2026
Q1 		$48.7K Hold
848
– – ﹤0.01% 4249
2025
Q4 		$15K Buy
+848
New +$25.3K ﹤0.01% 4413
2025
Q3 		– Sell
-30
Closed -$3.92K – 4438
2025
Q2 		$3.92K Hold
30
– – ﹤0.01% 4395
2025
Q1 		$3.55K Hold
30
– – ﹤0.01% 4412
2024
Q4 		$12.4K Hold
30
– – ﹤0.01% 4413
2024
Q3 		$28.4K Hold
30
– – ﹤0.01% 4296
2024
Q2 		$29.5K Hold
30
– – ﹤0.01% 4290
2024
Q1 		$27.6K Buy
+30
New +$23.5K ﹤0.01% 4302

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust's BIAF Position: Q2 2026 in Review

Northern Trust increased its bioAffinity Technologies (BIAF) stake by 32% in Q2 2026, buying an estimated $8.24K and bringing the position to 1,117 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4397.

Northern Trust first reported a position in BIAF in Q1 2024 and has held it in 9 quarters since. The position peaked at $48.7K in Q1 2026. 19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Northern Trust held 1,117 shares of bioAffinity Technologies worth $13.6K as of Q2 2026.
  • Northern Trust bought 269 bioAffinity Technologies shares in Q2 2026, an estimated $8.24K.
  • bioAffinity Technologies made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4397 holding.
  • Northern Trust first reported a position in bioAffinity Technologies in Q1 2024 and has held it in 9 quarters since.
  • Northern Trust's bioAffinity Technologies position peaked at $48.7K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.